PrimeCell Therapeutics Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 1

PrimeCell Therapeutics General Information

Description

Operator of a bio-med company focusing on discovering and clinical testing of biological drugs and medicinal technologies. The company offers stem cell treatment, somatic cell therapy, tissue engineering, gene therapy, cell testing and diagnostic services as well as offers regenerative medicines, cell carriers and nano-materials to support the regeneration of human tissues and organs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Clinics/Outpatient Services
Other Healthcare Services
Primary Office
  • Jáchymova 26/2
  • Prague, 110 00
  • Czech Republic
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PrimeCell Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PrimeCell Therapeutics‘s full profile, request access.

Request a free trial

PrimeCell Therapeutics Executive Team (8)

Name Title Board Seat Contact Info
Petr Čumba Chief Financial Officer
Serhiy Forostyak Ph.D Chief Scientific Officer
Michal Zahradníček Co-Founder & Chairman of the Board of Trustees
Lukáš Schůrek Co-Founder
Petr Koška Ph.D Chief Executive Officer & Vice Chairman, National Cell and Tissue Centre
You’re viewing 5 of 8 executive team members. Get the full list »

PrimeCell Therapeutics Board Members (3)

Name Representing Role Since
000 0000000 PrimeCell Therapeutics Member of the Board of Trustees 000 0000
000000 0000000íč00 PrimeCell Therapeutics Co-Founder & Chairman of the Board of Trustees 000 0000
0000 00š00 00.0 Self Chief Executive Officer & Vice Chairman, National Cell and Tissue Centre 000 0000
To view PrimeCell Therapeutics’s complete board members history, request access »

PrimeCell Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PrimeCell Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PrimeCell Therapeutics‘s full profile, request access.

Request a free trial